EphA2 as a glioma-associated antigen: a novel target for glioma vaccines (Q40365151)

19 September 2017

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines (English)

1 reference

19 September 2017

6

1 reference

19 September 2017

Walter J Storkus

9

0 references

Hideho Okada

10

object named as

Hideho Okada

1 reference

19 September 2017

3

Tomohide Tatsumi

1 reference

19 September 2017

Manabu Hatano

1

1 reference

19 September 2017

Junichi Eguchi

2

1 reference

19 September 2017

Naruo Kuwashima

4

1 reference

19 September 2017

Jill E Dusak

5

1 reference

19 September 2017

Ian F Pollack

7

1 reference

19 September 2017

Ronald L Hamilton

8

1 reference

19 September 2017

1 August 2005

1 reference

19 September 2017

1 reference

19 September 2017

7

1 reference

19 September 2017

8

1 reference

19 September 2017

717-722

1 reference

Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1501889

20 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16207473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immune selection after antigen-specific immunotherapy of melanoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16207473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1593/NEO.05277

1 reference

release_csmlvqwvifegtkrrhdu3ajwchq

19 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/csmlvqwvifegtkrrhdu3ajwchq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

19 September 2017

PubMed publication ID

16207473

1 reference